US 12,453,718 B2
Drug for treating or preventing cerebral hemorrhage, and method for treating or preventing cerebral hemorrhage using the drug
Teiji Tominaga, Sendai (JP); and Kuniyasu Niizuma, Sendai (JP)
Assigned to CORXEL PHARMACEUTICALS HONG KONG LIMITED, Shanghai (CN)
Filed by Corxel Pharmaceuticals Hong Kong Limited, Shanghai (CN)
Filed on Dec. 13, 2023, as Appl. No. 18/538,443.
Application 18/538,443 is a division of application No. 17/106,862, filed on Nov. 30, 2020, granted, now 11,850,232.
Prior Publication US 2024/0189280 A1, Jun. 13, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/407 (2006.01); A61P 7/04 (2006.01)
CPC A61K 31/407 (2013.01) [A61P 7/04 (2018.01)] 19 Claims
 
1. A method of reducing or suppressing a cerebral hemorrhage in a subject, the method comprising administering SMTP-7, or a pharmaceutically acceptable salt thereof, wherein the administering reduces neuronal damage, inflammation, or apoptosis in the subject.